Sawada K, Sato N, Tarumi T, Sakai N, Koizumi K, Sakurama S, Ieko M, Yasukouchi T, Koyanagawa Y, Yamaguchi M
Second Department of Internal Medicine, Hokkaido University School of Medicine, Japan.
Br J Haematol. 1993 Mar;83(3):349-58. doi: 10.1111/j.1365-2141.1993.tb04656.x.
The presence of serum or contaminant cells may alter clonal development of haematopoietic progenitor cells in vitro. To investigate the pathogenesis of myelodysplastic syndromes (MDS), marrow progenitor cells from 13 MDS patients were highly purified using monoclonal antibodies including CD34 and immunomagnetic microspheres. The cells positive for CD34 in the purified cells were in the range from 87% to 98%. These purified cells were cultured in serum-free medium with individual colony stimulating factors (CSFs) to investigate whether CD34+ cells from MDS patients have abnormal responses to individual CSFs. Dose response experiments with the purified CD34+ cells and recombinant human macrophage-CSF (rM-CSF), granulocyte-CSF (rG-CSF), granulocyte/macrophage-CSF (rGM-CSF), interleukin-3 (rIL-3) or erythropoietin (rEP) were performed in serum-free fibrin clots in 11 patients. Five patients showed a diminished response to rG-CSF and one patient to rEP. In the remaining six patients the purified CD34+ cells did not respond to a stimulation of any individual CSFs. The results indicate that the progenitor cell growth abnormalities in these disorders involve a defect in the capacity of progenitor cells to respond to stimulation with G-CSF, and present direct evidence for the manner in which myelodysplastic CD34+ cells are impaired.
血清或污染细胞的存在可能会在体外改变造血祖细胞的克隆发育。为了研究骨髓增生异常综合征(MDS)的发病机制,使用包括CD34在内的单克隆抗体和免疫磁珠对13例MDS患者的骨髓祖细胞进行了高度纯化。纯化细胞中CD34阳性细胞的比例在87%至98%之间。将这些纯化细胞在含有单个集落刺激因子(CSF)的无血清培养基中培养,以研究MDS患者的CD34+细胞对单个CSF是否有异常反应。对11例患者的纯化CD34+细胞与重组人巨噬细胞集落刺激因子(rM-CSF)、粒细胞集落刺激因子(rG-CSF)、粒细胞/巨噬细胞集落刺激因子(rGM-CSF)、白细胞介素-3(rIL-3)或促红细胞生成素(rEP)进行了无血清纤维蛋白凝块中的剂量反应实验。5例患者对rG-CSF反应减弱,1例患者对rEP反应减弱。在其余6例患者中,纯化的CD34+细胞对任何单个CSF的刺激均无反应。结果表明,这些疾病中的祖细胞生长异常涉及祖细胞对G-CSF刺激反应能力的缺陷,并为骨髓增生异常的CD34+细胞受损方式提供了直接证据。